Quarterly ResultAug 4, 2026, 04:16 PM
DaVita Q2 2026 Revenue $3.554B, EPS $4.02
AI Summary
DaVita Inc. announced strong financial results for the second quarter ended June 30, 2026, with consolidated revenues of $3.554 billion and diluted earnings per share of $4.02. The company reported robust operating cash flow of $490 million and free cash flow of $256 million. DaVita also continued its capital allocation strategy by repurchasing 2.2 million shares for $348 million and secured a $500 million incremental Term Loan B-2 tranche.
Key Highlights
- Consolidated revenues reached $3.554 billion for Q2 2026.
- Operating income was $579 million for the quarter.
- Diluted earnings per share (EPS) stood at $4.02.
- Operating cash flow was $490 million and free cash flow was $256 million.
- Repurchased 2.2 million shares for $348 million at $154.95 per share.
- Incurred a $500 million incremental Term Loan B-2 tranche.
- U.S. dialysis treatments totaled 7,226,600 for the quarter.
- Normalized non-acquired treatment growth was 0.3% year-over-year.
Price Impact
More from DVA